Φορτώνει......
Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)
PURPOSE: Treatment options for patients with advanced HNSCC are scarce. This phase II study was conducted to evaluate the safety, tolerability, PK, and efficacy of dasatinib in this setting. EXPERIMENTAL DESIGN: Patients with recurrent and/or metastatic HNSCC after platinum-based therapy were treate...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2010
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3117018/ https://ncbi.nlm.nih.gov/pubmed/21523723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25769 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|